Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
HIND
Stock Latest News
The Fly
Vyome reports Q1 EPS (15c) vs. ($761.59) last year
19d ago
HIND
Premium
The Fly
Vyome signs exclusive license agreement with Impetis
1M ago
HIND
Premium
The Fly
Vyome initiated with a Buy at Litchfield Hills
1M ago
HIND
Premium
Company Announcements
Vyome Holdings Shareholders Tighten Capital Structure at Meeting
2M ago
8K
HIND
Premium
Ratings
Vyome Therapeutics: Undervalued Buy on De-Risked VT-1953 Program and Pivotal Phase 3 Catalyst in a >$2B Orphan Market
2M ago
HIND
Premium
The Fly
Vyome Holdings presents Phase 2 study results on VT-1953
2M ago
HIND
Premium
The Fly
Vyome Holdings to present Phase 2 data on VT-1953 at AACR 2026
2M ago
HIND
Premium
The Fly
Vyome Holdings reports FY25 revenue $319.7k vs $246.9k last year
3M ago
HIND
Premium
Company Announcements
Vyome’s Livechain Acquires Humanyze to Expand AI HR Analytics
4M ago
8K
HIND
Premium
The Fly
Vyome Holdings publishes preclinical VT-1908 data
4M ago
HIND
Premium
Company Announcements
Vyome Reports Positive Phase 2 Data for VT-1953 Gel
4M ago
8K
HIND
Premium
The Fly
Vyome Holdings funds budget for VT-1953 study
4M ago
HIND
Premium
Company Announcements
Vyome Holdings Highlights VT-1953 Market Potential Analysis
5M ago
8K
HIND
Premium
Company Announcements
Vyome’s LiveChain Signs LOI for Humanyze Note Acquisition
6M ago
8K
HIND
Premium
Ratings
Vyome Holdings: Promising Advancements in MFW Treatment and Strategic Market Positioning Drive Buy Rating
6M ago
HIND
Premium
The Fly
Vyome Holdings announces VT-1953 trial achieves primary, secondary endpoints
6M ago
HIND
Premium
Company Announcements
Vyome Holdings Inc. Reports Post-Merger Financials
7M ago
HIND
Premium
Ratings
Vyome Holdings: Buy Rating Backed by Promising Pipeline and Strategic Growth Potential
7M ago
HIND
Premium
The Fly
Vyome Holdings files to sell 610K shares of common stock for holders
7M ago
HIND
Premium
Company Announcements
Vyome Holdings Elects Directors at Annual Meeting
8M ago
8K
HIND
Premium
Company Announcements
Vyome Holdings Acquires AI Startup Oculo, Inc.
9M ago
8K
HIND
Premium
The Fly
Vyome Holdings upgraded to Buy at Maxim on immuno-inflammatory pipeline
9M ago
HIND
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
